| |
- Statistical Considerations in the Intention-To-Treat Principle.
Biopharmaceutical applied statistics symposium. Hilton Head, SC,
12/8/97.
-
The Intention -To-Treat Principle And Its Implications For The Design,
Conduct And Analysis Of Clinical Trails.
Food and Drug Administration, March 17, 1999.
- The Role of a Data and Safety Monitoring
Board in Phase III Clinical Trials. Drug Information Association 6th
Annual Biotechnology Workshop on Clinical Trials and Product
development in Biotechnology.
|
|
|
